These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17364892)

  • 1. Chemokine transport across human vascular endothelial cells.
    Mordelet E; Davies HA; Hillyer P; Romero IA; Male D
    Endothelium; 2007; 14(1):7-15. PubMed ID: 17364892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
    Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
    J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
    Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
    Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas.
    Kabashima H; Yoneda M; Nagata K; Hirofuji T; Ishihara Y; Yamashita M; Maeda K
    Cytokine; 2001 Oct; 16(2):62-6. PubMed ID: 11683586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2 expression by brain microvascular endothelial cells is critical for macrophage transendothelial migration in response to CCL2.
    Dzenko KA; Song L; Ge S; Kuziel WA; Pachter JS
    Microvasc Res; 2005 Jul; 70(1-2):53-64. PubMed ID: 15927208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CXC chemokine IP-10 in testicular germ cell tumours.
    Schweyer S; Soruri A; Baumhoer D; Peters J; Cattaruzza M; Radzun HJ; Fayyazi A
    J Pathol; 2002 May; 197(1):89-97. PubMed ID: 12081209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II.
    Pechkovsky DV; Goldmann T; Ludwig C; Prasse A; Vollmer E; Müller-Quernheim J; Zissel G
    Respir Res; 2005 Jul; 6(1):75. PubMed ID: 16033640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines.
    Goldberg-Bittman L; Neumark E; Sagi-Assif O; Azenshtein E; Meshel T; Witz IP; Ben-Baruch A
    Immunol Lett; 2004 Mar; 92(1-2):171-8. PubMed ID: 15081542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration.
    Hillyer P; Mordelet E; Flynn G; Male D
    Clin Exp Immunol; 2003 Dec; 134(3):431-41. PubMed ID: 14632748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase.
    Stamatovic SM; Keep RF; Kunkel SL; Andjelkovic AV
    J Cell Sci; 2003 Nov; 116(Pt 22):4615-28. PubMed ID: 14576355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcellular transport of CCL2 across brain microvascular endothelial cells.
    Ge S; Song L; Serwanski DR; Kuziel WA; Pachter JS
    J Neurochem; 2008 Mar; 104(5):1219-32. PubMed ID: 18289346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan.
    Soejima K; Rollins BJ
    J Immunol; 2001 Dec; 167(11):6576-82. PubMed ID: 11714827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular characteristics of neuroblastoma cells: regulation by the ELR--CXC chemokine CXCL10 and expression of a CXCR3-like receptor.
    Goldberg-Bittman L; Sagi-Assif O; Meshel T; Nevo I; Levy-Nissenbaum O; Yron I; Witz IP; Ben-Baruch A
    Cytokine; 2005 Feb; 29(3):105-17. PubMed ID: 15613278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of blocking the CXCL9/10-CXCR3 chemokine system in the outcome of endothelial-target rickettsial infections.
    Valbuena G; Walker DH
    Am J Trop Med Hyg; 2004 Oct; 71(4):393-9. PubMed ID: 15516632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
    Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
    Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine.
    Marro ML; Daniels DA; McNamee A; Andrew DP; Chapman TD; Jiang MS; Wu Z; Smith JL; Patel KK; Gearing KL
    Biochemistry; 2005 Jun; 44(23):8449-60. PubMed ID: 15938634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.